Optimizing First-Line Care in Advanced Melanoma: From Clinical Evidence to Patient-Centered Practice
As the treatment landscape for advanced melanoma evolves, achieving durable, long-term survival has become the new clinical benchmark. Stay at the forefront of oncology with our latest educational resources.
Watch our expert-led webinar featuring Dr. Megan Mahoney and Dr. Chloé Béland to explore the evidence behind first-line therapy choices and the nuances of shared decision-making. Complement your learning by downloading our exclusive infographic on the RELATIVITY-047 4-year update, providing a clear look at the long-term efficacy and safety of nivolumab and relatlimab. Equip yourself with the data and strategies needed to optimize individualized care for your patients.
Navigating First-Line Therapy Choices in Advanced Melanoma: Evidence, Patient Factors, and Shared Decision-Making
Download the Infographic to transform your first-line clinical decision-making and enhance long-term survivorship strategies for your patients.
Supported by unrestricted educational funding from Bristol-Myers Squibb.
